R. Haring

发表

Mitogen‐Activated Protein Kinase‐Dependent and Protein Kinase C‐Dependent Pathways Link the m1 Muscarinic Receptor to β‐Amyloid Precursor Protein Secretion

Y. Kloog, A. Fisher, E. Heldman, 1998 .

New M1 Agonists: Selective Signaling, Neurotrophic-Like and Cognitive Effects — Implications in the Treatment of Alzheimer’s Disease

D. Gurwitz, Z. Vogel, A. Fisher, 1995 .

Rigid analogs of acetylcholine can be m1-selective agonists: implications for a rational treatment strategy in Alzheimer's disease

D. Gurwitz, Z. Vogel, A. Fisher, 1992 .

New Muscarinic Agonists with Special Emphasis on AF102B

C. Fraser, D. Gurwitz, A. Fisher, 1991 .

Bioactive lipids and their receptors.

R. Haring, I. Angel, Adina Bar, 2002, Current opinion in drug discovery & development.

Novel M1 Agonists: From Symptomatic Treatment Towards Delaying the Progression of Alzheimer’s Disease

D. Gurwitz, E. Sadot, A. Fisher, 1997 .

Ligand-selective signaling and high-content screening for GPCR drugs.

D. Gurwitz, R. Haring, 2003, Drug discovery today.

Nerve cell death induced by Ca2+ ionophores in dissociated hippocampal cultures. Protective action of the NMDA antagonist MK-801.

A. Futerman, A. Shahar, R. Haring, 1997, Advances in experimental medicine and biology.

Selective neurotoxicity induced by lasalocid in dissociated cerebral cultures.

D. Gurwitz, A. Shahar, R. Haring, 1993, Toxicology in vitro : an international journal published in association with BIBRA.

Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel.

Y. Kloog, R. Haring, M. Sokolovsky, 1988, Biochemistry.

Localization of phencyclidine binding sites on alpha and beta subunits of the nicotinic acetylcholine receptor from Torpedo ocellata electric organ using azido phencyclidine

Y. Kloog, R. Haring, M. Sokolovsky, 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer's amyloid precursor protein.

D. Gurwitz, A. Fisher, H. Danenberg, 1996, Life sciences.

Glycine‐Like Modulation of N‐Methyl‐d‐Aspartate Receptors by a Monoclonal Antibody That Enhances Long‐Term Potentiation

P. Stanton, M. Scheideler, J. Moskal, 1991, Journal of neurochemistry.

Quantitative GLC determination of conjugated estrogens in raw materials and finished dosage forms.

R. Haring, B. Kho, G. Schilling, 1975, Journal of pharmaceutical sciences.

Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum

A. Fisher, J. Barg, E. Heldman, 1996, Brain Research.

Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands.

C. Fraser, D. Gurwitz, A. Fisher, 1994, European journal of pharmacology.

Selective Signaling via Unique Ml Muscarinic Agonists a

M. Segal, D. Gurwitz, Z. Vogel, 1993, Annals of the New York Academy of Sciences.

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease

A. Fisher, R. Haring, Z. Pittel, 2007, Journal of Molecular Neuroscience.

Identification of polypeptides of the phencyclidine receptor of rat hippocampus by photoaffinity labeling with [3H]azidophencyclidine.

Y. Kloog, R. Haring, M. Sokolovsky, 1986, Biochemistry.

Regional heterogeneity of rat brain phencyclidine (PCP) receptors revealed by photoaffinity labeling with [3H] azido phencyclidine.

Y. Kloog, R. Haring, M. Sokolovsky, 1985, Biochemical and biophysical research communications.

Photoaffinity labeling and binding studies reveal the existence of two types of phencyclidine receptors in the NCB-20 cell line

R. Zukin, S. Zukin, R. Haring, 1990, Neuroscience Letters.

Binding studies and photoaffinity labeling identify two classes of phencyclidine receptors in rat brain.

Y. Kloog, R. Haring, M. Sokolovsky, 1987, Biochemistry.

Multiple mode of binding of phencyclidines: high affinity association between phencyclidine receptors in rat brain and a monovalent ion-sensitive polypeptide.

Y. Kloog, R. Haring, M. Sokolovsky, 1987, Biochemical and biophysical research communications.

Species differences determine azido phencyclidine labeling pattern in desensitized nicotinic acetylcholine receptors.

Y. Kloog, R. Haring, M. Sokolovsky, 1983, Biochemical and biophysical research communications.

Characterization of the interaction of phencyclidine and its derivatives with the ionic channel of the nicotinic receptor.

R. Haring, M. Sokolovsky, A. Kalir, 1983, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Multiple binding sites for phencyclidine on the nicotinic acetylcholine receptor from Torpedo ocellata electric organ.

Y. Kloog, R. Haring, 1984, Life sciences.

Muscarinic Modulation of β-Amyloid Precursor Protein (βApp) Processing in Vitro and in Vivo

A. Fisher, E. Heldman, R. Haring, 1998 .

M1 Muscarinic Agonists as a Therapeutic Strategy in Alzheimer’s Disease

A. Fisher, R. Haring, Z. Pittel, 2002 .

Impact of muscarinic agonists for successful therapy of Alzheimer's disease.

A. Fisher, R. Haring, Z. Pittel, 2002, Journal of neural transmission. Supplementum.

M1 Agonists for the Treatment of Alzheimer's Disease.

D. Gurwitz, Z. Vogel, R. Verchovsky, 1996, Annals of the New York Academy of Sciences.

Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis

A. Fisher, Y. Karton, E. Heldman, 1998, Journal of Physiology-Paris.

NGF promotes amyloid precursor protein secretion via muscarinic receptor activation.

D. Gurwitz, H. Danenberg, J. Barg, 1995, Biochemical and biophysical research communications.

NGF-dependent neurotrophic-like effects of AF102B, an M1 muscarinic agonist, in PC12M1 cells.

D. Gurwitz, A. Fisher, R. Stein, 1995, Neuroreport.

Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist AF102B.

D. Gurwitz, A. Fisher, Y. Karton, 1994, Biochemical and biophysical research communications.

Conjugated estrogens bioinequivalence: comparison of four products in postmenopausal women.

R. Haring, W. Adams, J. Hasegawa, 1979, Journal of pharmaceutical sciences.

Localization of azidophencyclidine-binding site on the nicotinic acetylcholine receptor alpha-subunit.

J. Gershoni, Y. Kloog, R. Haring, 1987, Biochemical and biophysical research communications.

(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.

D. Gurwitz, A. Fisher, E. Heldman, 1991, The Journal of pharmacology and experimental therapeutics.

Dehydroepiandrosterone Augments M1‐Muscarinic Receptor‐Stimulated Amyloid Precursor Protein Secretion in Desensitized PC12M1 Cells

D. Gurwitz, A. Fisher, D. Ben-Nathan, 1995, Annals of the New York Academy of Sciences.

M1 Muscarinic Agonists as Potential Disease‐Modifying Agents in Alzheimer's Disease: Rationale and Perspectives

A. Fisher, R. Haring, Z. Pittel, 2000, Annals of the New York Academy of Sciences.

Ml Muscarinic Agonists: From Treatment Toward Delaying Progression of Alzheimer’s Disease

A. Fisher, Y. Karton, E. Heldman, 1998 .

Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion.

Y. Kloog, E. Heldman, R. Haring, 1998, Journal of neurochemistry.